The Effect of Gut Sterilisation on Macrophage Activation in Patients With Alcoholic Hepatitis.
NCT03157388 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2019-05-23
Summary
Alcoholic hepatitis (AH) is a severe alcohol induced hepatic inflammation that leads to jaundice and liver failure. Gut derived bacterial translocation to the liver is currently thought to be one of the main inflammatory drivers of the disease.
This project investigates the effects of gut sterilisation with broad spectrum antibiotics in patients with AH
Conditions
- Alcoholic Hepatitis
Interventions
- DRUG
-
Combined Vancomycin and Gentamycin and Meropenem
The following combined antibiotic regime will be administered for eradication of gut bacteria. 7 days combined antibiotic treatment, per oral route, once daily: vancomycin 500 mg (Vancomycin "Hospira"), powder for concentrate and gentamycin 40 mg ("Hexamycin®"), solution and meropenem 500 mg (Meropenem "Hospira"), powder for concentrate; The three drugs are dissolved and combined in approximately 100 ml of apple juice.
Sponsors & Collaborators
-
University of Aarhus
lead OTHER
Principal Investigators
-
Hendrik D Vilstrup, Professor · Aarhus University Hospital
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-06-01
- Primary Completion
- 2018-06-01
- Completion
- 2018-12-01
Countries
- Denmark
Study Locations
More Related Trials
-
Rifaximin Predicts the Complications of Decompensated Cirrhosis
NCT02074280 ·Status: UNKNOWN ·Phase: PHASE4
-
Identification of Gut Microbiome Biomarkers Associated to Acquisition of Enterobacteriae Highly Resistant to Third Generation Cephalosporines Following Ceftriaxone Treatment.
NCT03569917 ·Status: TERMINATED ·Phase: NA
-
Vancomycin Resistant Enterococci in Patients Awaiting Liver Transplantation at the University of Michigan: Prevalence, Risk Factors, Natural History and Outcome of Colonization
NCT00005667 ·Status: UNKNOWN
-
Existence in the Human Digestive Flora of Phages Able to Prevent the Acquisition of Multiresistant Enterobacteria
NCT03231267 ·Status: UNKNOWN
-
Microbiota Study in Liver Transplanted Patients
NCT03507140 ·Status: COMPLETED
-
Effect of Antibiotics on Gut Microbiome and Plasma Metabolome
NCT03273296 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Gastroenteritis: Development of PCR Analysis and Algorithm for Fast Clarification of Isolation Indication
NCT02685527 ·Status: COMPLETED
-
Impact of Prescription Quality, Infection Control and Antimicrobial Stewardship on Gut Microbiota Domination by Healthcare-Associated Pathogens
NCT03765528 ·Status: UNKNOWN
-
Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation
NCT06782880 ·Status: RECRUITING ·Phase: NA
-
The Finnish Faecal Microbiota Transplantation Study (FINFMT)
NCT03732131 ·Status: RECRUITING
-
Bowel Colonization With Multi-drug Resistant Bacterial Species in Hospitalized Patients With acute-on Chronic Liver Failure (ACLF), and Its Relationship With Extra-intestinal Infectious Events and Short-term Outcomes.
NCT04383106 ·Status: COMPLETED
-
Prophylactic Antibiotics in Admitted Cirrhotics
NCT04218695 ·Status: COMPLETED ·Phase: PHASE4
-
PRObing The Efficacy of Commercial Stage Storage Buffers and Evaluating Gut Metaproteome Variability Between Individuals
NCT06423508 ·Status: RECRUITING
-
Clinical and Biological Impact of Gut Microbiota in Adult Patients With Bacteremia During the COVID-19 Pandemic
NCT07183722 ·Status: ACTIVE_NOT_RECRUITING
-
Role of Gut Microbiota in the Pathophysiology of Aseptic Abscesses
NCT05537909 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Heterologous Fecal microbiotA Transfer in ICU Patients: a FeasibilitY and SafetY StudY
NCT03350178 ·Status: TERMINATED ·Phase: PHASE2
-
Amplification and Selection of Antimicrobial Resistance in the Intestine II
NCT03140826 ·Status: COMPLETED
-
Human Microbiota and Liver Transplant
NCT02223468 ·Status: COMPLETED
-
Fecal Microbiota Transplantation (FMT) to Decolonize Antibiotic - Resistant Bacteria (ARB) - New Protocol
NCT06156956 ·Status: RECRUITING ·Phase: NA
-
Fecal Microbiota Transplantation (FMT) in the Treatment of Pouchitis
NCT03378921 ·Status: COMPLETED ·Phase: PHASE2
-
Appendicectomy Versus Antibiotics in the Treatment of Acute Uncomplicated Appendicitis
NCT01022567 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Comparison of Different Methods for the Analysis of Gut Microbiome Composition
NCT04082221 ·Status: COMPLETED
-
International Surveillance of Antimicrobial Resistance in Cirrhosis-Related Infections
NCT06634940 ·Status: RECRUITING
-
Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives
NCT03250104 ·Status: COMPLETED
-
Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread
NCT02666274 ·Status: UNKNOWN